Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Alkyl-2-acetylglycerophosphocholine Esterase (metabolism) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000081 (1999) E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B YoudimApomorphine protects against MPTP-induced neurotoxicity in mice.
000268 (2000) D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J LangstonRelationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000279 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000538 (2001) E C Maratos [Royaume-Uni] ; M J Jackson ; R K Pearce ; P. JennerAntiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).
000539 (2001) S H Fox [Royaume-Uni] ; B. Henry ; M P Hill ; D. Peggs ; A R Crossman ; J M BrotchieNeural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
000580 (2001) R E Yee [États-Unis] ; I. Irwin ; C. Milonas ; D B Stout ; S C Huang ; K. Shoghi-Jadid ; N. Satyamurthy ; L E Delanney ; D M Togasaki ; K F Farahani ; K. Delfani ; A M Janson ; M E Phelps ; J W Langston ; J R BarrioNovel observations with FDOPA-PET imaging after early nigrostriatal damage.
000927 (2002) Susan H. Fox [Royaume-Uni] ; Brian Henry ; Michael Hill ; Alan Crossman ; Jonathan BrotchieStimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
000946 (2002) Mikko Kuoppam Ki [Royaume-Uni] ; Ghassan Al-Barghouthy ; Michael Jackson ; Lance Smith ; Bai-Yun Zeng ; Niall Quinn ; Peter JennerBeginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.
000975 (2003) Jay S. Schneider [États-Unis] ; Timothy V. WadeExperimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
000A92 (2003) Michael Orth [Royaume-Uni] ; Sarah J. TabriziModels of Parkinson's disease.
000B35 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P J BédardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000B40 (1992) B. Gomez-Mancilla [Canada] ; J F Latulippe ; R. Boucher ; P J BédardEffect of ethosuximide on rest tremor in the MPTP monkey model.
001591 (2006) Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston ; Naomi P. Visanji ; Susan H. Fox ; Jonathan M. BrotchieHistamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
001774 (2006) Gloria E. Meredith [États-Unis] ; Un Jung KangBehavioral models of Parkinson's disease in rodents: a new look at an old problem.
001795 (2006) Susan H. Fox [Canada] ; Anthony E. Lang ; Jonathan M. BrotchieTranslation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure.
001831 (2006) Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez ; Tom H. Johnston ; Donna Pires ; Valerie Voon ; Jonathan M. Brotchie ; Susan H. FoxPharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
001B33 (2007) Regina Katzenschlager [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; Kim Stockwell ; Kayhan A. Tayarani-Binazir ; Mohammed Zubair ; Lance A. Smith ; Peter Jenner ; Andrew J. LeesAntiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
001D24 (1991) T Z Aziz [Royaume-Uni] ; D. Peggs ; M A Sambrook ; A R CrossmanLesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
002003 (2008) Jose L. Lanciego [Espagne] ; Maria C. Rodríguez-Oroz [Espagne] ; Francisco J. Blesa [Espagne] ; Lydia Alvarez-Erviti [Espagne] ; Jorge Guridi [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Yoland Smith [États-Unis] ; Jose A. Obeso [Espagne]Lesion of the Centromedian Thalamic Nucleus in MPTP-Treated Monkeys
002C11 (1991) R. Kurlan [États-Unis] ; M H Kim ; D M GashOral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
002F24 (2010) Marta G. Vu Kovi [États-Unis] ; Quanzheng Li [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis]Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson’s Disease: In Vivo Imaging with [18F]Fallypride

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024